Perry-Thomas, Cherron – Trademark Portfolio

Entity Type: 01

Perry-Thomas, Cherron has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include BLACK CANNABIS WEEK. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 25 (Clothing) and Class 41 (Education & Entertainment). This trademark owner is based in Philadelphia, PA.

5111 Pulaski Ave

Philadelphia, PA 19144

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Perry-Thomas, Cherron's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does Perry-Thomas, Cherron have?

Perry-Thomas, Cherron has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does Perry-Thomas, Cherron file in?

Perry-Thomas, Cherron files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 41 (Education & Entertainment), Class 31 (Natural Agricultural Products). Class 25 covers clothing, footwear, headgear.

What are Perry-Thomas, Cherron's most well-known trademarks?

Perry-Thomas, Cherron's registered trademark portfolio includes well-known marks such as BLACK CANNABIS WEEK. These are among 1 currently registered trademark in the portfolio.

What is Perry-Thomas, Cherron's trademark registration success rate?

Perry-Thomas, Cherron has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.